Beyond research summary
A strong claim needs the right evidence.
Federal Trade Commission · December 2022 · Health Products Compliance Guidance
Agency guidance · advertising substantiation
An original Beyond research note—not the original publication, a patient recommendation or an agency endorsement.
The question
The FTC explains how advertisers should substantiate health-product claims and avoid misleading consumers. Its focus is what an advertisement communicates—including implied promises—not just whether its individual words sound cautious.
How they approached it
This is interpretive guidance illustrated with advertising examples, not an experiment. It explains how the FTC applies its truth-in-advertising principles to health products. Scientific quality, relevance to the advertised product and the overall body of evidence matter together.
What was measured?
The guidance measures no absorption endpoint. Instead, it asks whether the evidence can support the actual claim consumers receive. Health-benefit claims generally require competent and reliable scientific evidence, typically well-designed randomized controlled human testing appropriate to the claim.
What the resource explains
“High absorption” raises questions about the endpoint, comparison and population. “Clinically tested” describes testing but can imply proven benefit in context; merely conducting a study does not establish that benefit. An “X times” comparison needs a defined comparator, relevant conditions and evidence for the stated difference. These are Beyond’s examples of applying the principles—not quotations or approved packaging language.
What we can conclude
Read a claim and its evidence as a pair. Identity or purity testing cannot substitute for an absorption study. A cell result cannot, by itself, substantiate a promise of better human health. Qualifying text must clarify the message rather than contradict a prominent promise.
Where the limits sit
The guidance is not a certification scheme, a scientific ranking of endpoints or a legal opinion about any particular product. Different claims require different evidence. Linking to it does not mean the FTC has reviewed or endorsed Beyond.
Relevance to Beyond
A hypothesis, read in context.
For Beyond Iron+, we distinguish ingredient hypotheses, cell and animal observations, and planned human research. That separation helps avoid converting an interesting laboratory finding into a claim about a finished product. Return to the label decoder to ask what a phrase actually promises—and which test would answer it.
Source & bibliography
The original belongs to its publisher.
Federal Trade Commission (2022). Health Products Compliance Guidance. United States: FTC business guidance.
Official agency guidance · not a clinical study or product approval
This page contains Beyond’s original interpretation only. The publication or agency resource is not hosted or reproduced here. Access to the original may depend on the publisher.
Read official guidance (opens in a new tab)Keep exploring
Different sources. Different questions.
Agency education · nutrition labeling
Research note: FDA · what Daily Value meansLaboratory · intestinal-cell model
Research note: Feng & Mine · iron uptake in cellsHuman · randomized equivalence trial
Research note: Li · iron with or without vitamin C